Rituximab-Induced Kaposi Sarcoma in HIV-Negative Patients: A Narrative Review

por Oprita, Alexandru, Cotan, Horia, Celmare, Dana, Emilescu, Radu
Publicado 2023

The Effect of Β-Arrestin2 Overexpression Regarding Viability and Temozolomide Treatment in High-Grade Glioma Cells

por OPRITA, ALEXANDRU, STAICU, GEORGIANA ADELINE, BALOI, CARINA, DRICU, ANICA, ARTENE, STEFAN ALEXANDRU
Publicado 2022

Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches

por Alexandru, Oana, Horescu, Cristina, Sevastre, Ani-Simona, Cioc, Catalina Elena, Baloi, Carina, Oprita, Alexandru, Dricu, Anica
Publicado 2020

Combined Effects of Doxorubicin and Temozolomide in Cultured Glioblastoma Cells

por BALOI, CARINA, OPRITA, ALEXANDRU, SEMENESCU, LILIANA ELEONORA, TACHE, DANIELA ELISE, POPESCU, OANA STEFANA, STAICU, GEORGIANA ADELINE, DRICU, ANICA
Publicado 2022

Updated Insights on EGFR Signaling Pathways in Glioma

por Oprita, Alexandru, Baloi, Stefania-Carina, Staicu, Georgiana-Adeline, Alexandru, Oana, Tache, Daniela Elise, Danoiu, Suzana, Micu, Elena Simona, Sevastre, Ani-Simona
Publicado 2021

ELTD1—An Emerging Silent Actor in Cancer Drama Play

por Sevastre, Ani-Simona, Buzatu, Iuliana M., Baloi, Carina, Oprita, Alexandru, Dragoi, Alexandra, Tataranu, Ligia G., Alexandru, Oana, Tudorache, Stefania, Dricu, Anica
Publicado 2021

In vitro evaluation of Axitinib and Sorafenib treatment in glioblastoma cell viability and morphology

por Opriţa, Alexandru, Dobrescu, Mihaela Amelia, Manea, Elena Victoria, Popescu, Ştefana Oana, Sevastre, Ani Simona, Pîrvu, Andreea Silvia, Buzatu, Iuliana Mihaela, Tache, Daniela Elise
Publicado 2023

Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer

por Pirlog, Cristina-Florina, Cotan, Horia Teodor, Parosanu, Andreea, Orlov Slavu, Cristina, Popa, Ana Maria, Iaciu, Cristian, Olaru, Mihaela, Oprita, Alexandru Vlad, Nita, Irina, Nitipir, Cornelia
Publicado 2022

Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?

por Pîrlog, Cristina-Florina, Costache, Raluca, Paroșanu, Andreea Ioana, Slavu, Cristina Orlov, Olaru, Mihaela, Popa, Ana Maria, Iaciu, Cristian, Niță, Irina, Moțatu, Pompilia, Cotan, Horia Teodor, Oprița, Alexandru Vlad, Costache, Daniel, Manolescu, Loredana Sabina Cornelia, Nițipir, Cornelia
Publicado 2023